English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT

Released

Journal Article

The methyl group of N-alpha(Me)Arg-containing peptides disturbs the active-site geometry of thrombin, impairing efficient cleavage

MPS-Authors
/persons/resource/persons78142

Huber,  R.
Huber, Robert / Structure Research, Max Planck Institute of Biochemistry, Max Planck Society;

/persons/resource/persons77772

Bode,  W.
Fässler, Reinhard / Molecular Medicine, Max Planck Institute of Biochemistry, Max Planck Society;
Huber, Robert / Structure Research, Max Planck Institute of Biochemistry, Max Planck Society;
Conti, Elena / Structural Cell Biology, Max Planck Institute of Biochemistry, Max Planck Society;

External Resource
No external resources are shared
Fulltext (restricted access)
There are currently no full texts shared for your IP range.
Fulltext (public)
There are no public fulltexts stored in PuRe
Supplementary Material (public)
There is no public supplementary material available
Citation

Friedrich, R., Steinmetzer, T., Huber, R., Stürzebecher, J., & Bode, W. (2002). The methyl group of N-alpha(Me)Arg-containing peptides disturbs the active-site geometry of thrombin, impairing efficient cleavage. Journal of Molecular Biology, 316(4), 869-874.


Cite as: https://hdl.handle.net/11858/00-001M-0000-0010-6F94-9
Abstract
Bivalent peptidic thrombin inhibitors consisting of an N- terminal D-cyclohexylalanine-Pro-N-alpha(Me)Arg active-site fragment, a flexible polyglycine linker, and a C-terminal hirugen-like segment directed towards the fibrinogen recognition exosite inhibit thrombin with K-i values in the pico-molar range, remaining stable in buffered solution at pH 7.8 for at least 15 hours. In order to investigate the structural basis of this increased, stability, the most potent of these inhibitors, I-11 (K-i = 37pM), containing an N- alpha(Me)Arg-Thr bond, was crystallized in complex with human a-thrombin. X-ray data were collected to 1.8 Angstrom resolution and the crystal structure of this complex was determined. The Fourier map displays clear electron density for the N-terminal fragment and for the exosite binding segment. It indicates, however, that in agreement with Edman sequencing, the peptide had been cleaved in the crystal, presumably due to the long incubation time of 14 days needed for crystallization and data collection. The N-alpha(Me) group is directed toward the carbonyl oxygen atom of Ser214, pushing the Ser195 O-gamma atom out of its normal site. This structure suggests that upon thrombin binding, the scissile peptide bond of the intact peptide and the Ser195 O-gamma are separated from each other, impairing the nucleophilic attack of the Ser195 07 toward the N-chi(Me)Arg carbonyl group. In the time-scale of two weeks, however, cleavage geometries favoured by the crystal allow catalysis at a slow rate. (C) 2002 Elsevier Science Ltd.